These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 32417903)
1. Efficacy of dalbavancin against MRSA biofilms in a rat model of orthopaedic implant-associated infection. Silva V; Antão HS; Guimarães J; Prada J; Pires I; Martins Â; Maltez L; Pereira JE; Capelo JL; Igrejas G; Poeta P J Antimicrob Chemother; 2020 Aug; 75(8):2182-2187. PubMed ID: 32417903 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of dalbavancin in a rat model of methicillin-resistant Staphylococcus aureus (MRSA)-osteomyelitis. Silva V; Miranda C; Antão HS; Guimarães J; Prada J; Pires I; Maltez L; Pereira JE; Capelo JL; Igrejas G; Poeta P Int J Antimicrob Agents; 2020 Jul; 56(1):106021. PubMed ID: 32439480 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of dalbavancin in the treatment of MRSA rat sternal osteomyelitis with mediastinitis. Barnea Y; Lerner A; Aizic A; Navon-Venezia S; Rachi E; Dunne MW; Puttagunta S; Carmeli Y J Antimicrob Chemother; 2016 Feb; 71(2):460-3. PubMed ID: 26518048 [TBL] [Abstract][Full Text] [Related]
4. Anti-biofilm activity of dalbavancin against methicillin-resistant Silva V; Miranda C; Bezerra M; Antão HS; Guimarães J; Prada J; Pires I; Maltez L; Pereira JE; Capelo JL; Igrejas G; Poeta P J Chemother; 2021 Nov; 33(7):469-475. PubMed ID: 33904369 [TBL] [Abstract][Full Text] [Related]
5. Activity of dalbavancin, alone and in combination with rifampicin, against meticillin-resistant Staphylococcus aureus in a foreign-body infection model. Baldoni D; Furustrand Tafin U; Aeppli S; Angevaare E; Oliva A; Haschke M; Zimmerli W; Trampuz A Int J Antimicrob Agents; 2013 Sep; 42(3):220-5. PubMed ID: 23880168 [TBL] [Abstract][Full Text] [Related]
6. Dalbavancin for treatment of implant-related methicillin-resistant Staphylococcus aureus osteomyelitis in an experimental rat model. Kussmann M; Obermueller M; Berndl F; Reischer V; Veletzky L; Burgmann H; Poeppl W Sci Rep; 2018 Jun; 8(1):9661. PubMed ID: 29941909 [TBL] [Abstract][Full Text] [Related]
7. A novel rodent model of chronic spinal implant-associated infection. DeMourdant T; Rajkovic CJ; Tracz JA; Perdomo-Pantoja A; Judy BF; Hernandez VN; Lin J; Lazzari JL; Dikeman DA; Archer NK; Davis KM; Gordon O; Witham TF Spine J; 2023 Sep; 23(9):1389-1399. PubMed ID: 37247639 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of dalbavancin against methicillin-resistant Staphylococcus aureus in the rat granuloma pouch infection model. Jabés D; Candiani G; Romanó G; Brunati C; Riva S; Cavaleri M Antimicrob Agents Chemother; 2004 Apr; 48(4):1118-23. PubMed ID: 15047510 [TBL] [Abstract][Full Text] [Related]
10. Cathodic Voltage-controlled Electrical Stimulation Plus Prolonged Vancomycin Reduce Bacterial Burden of a Titanium Implant-associated Infection in a Rodent Model. Nodzo SR; Tobias M; Ahn R; Hansen L; Luke-Marshall NR; Howard C; Wild L; Campagnari AA; Ehrensberger MT Clin Orthop Relat Res; 2016 Jul; 474(7):1668-75. PubMed ID: 26801677 [TBL] [Abstract][Full Text] [Related]
11. Multiple Weekly Dalbavancin Dosing for the Treatment of Native Vertebral Osteomyelitis Caused by Methicillin-Resistant Staphylococcus Aureus: A Case Report. Almangour TA; Fletcher V; Alessa M; Alhifany AA; Tabb D Am J Case Rep; 2017 Dec; 18():1315-1319. PubMed ID: 29222405 [TBL] [Abstract][Full Text] [Related]
12. A novel antibacterial compound decreases MRSA biofilm formation without the use of antibiotics in a murine model. Bouloussa H; Durand Z; Gibon E; Chen AF; Grant M; Saleh-Mghir A; Mirza M; Stutzman B; Vergari C; Yue J; Anzala N; Bonnot D; Albac S; Bouloussa O; Croisier D J Orthop Res; 2024 Jan; 42(1):202-211. PubMed ID: 37283215 [TBL] [Abstract][Full Text] [Related]
13. Novel rat model of methicillin-resistant Staphylococcus aureus-infected silicone breast implants: a study of biofilm pathogenesis. Arad E; Navon-Venezia S; Gur E; Kuzmenko B; Glick R; Frenkiel-Krispin D; Kramer E; Carmeli Y; Barnea Y Plast Reconstr Surg; 2013 Feb; 131(2):205-214. PubMed ID: 23076419 [TBL] [Abstract][Full Text] [Related]
14. Comparative activities of vancomycin, tigecycline and rifampin in a rat model of methicillin-resistant Staphylococcus aureus osteomyelitis. Vergidis P; Schmidt-Malan SM; Mandrekar JN; Steckelberg JM; Patel R J Infect; 2015 Jun; 70(6):609-15. PubMed ID: 25576292 [TBL] [Abstract][Full Text] [Related]
15. Bacteriophage therapy in implant-related infections: an experimental study. Yilmaz C; Colak M; Yilmaz BC; Ersoz G; Kutateladze M; Gozlugol M J Bone Joint Surg Am; 2013 Jan; 95(2):117-25. PubMed ID: 23324958 [TBL] [Abstract][Full Text] [Related]
16. In vitro time-kill kinetics of dalbavancin against Staphylococcus spp. biofilms over prolonged exposure times. Di Pilato V; Ceccherini F; Sennati S; D'Agostino F; Arena F; D'Atanasio N; Di Giorgio FP; Tongiani S; Pallecchi L; Rossolini GM Diagn Microbiol Infect Dis; 2020 Feb; 96(2):114901. PubMed ID: 31761480 [TBL] [Abstract][Full Text] [Related]
18. Can dalbavancin be used as a catheter lock solution? Díaz-Ruíz C; Alonso B; Cercenado E; Cruces R; Bouza E; Muñoz P; Guembe M J Med Microbiol; 2018 Jul; 67(7):936-944. PubMed ID: 29771236 [No Abstract] [Full Text] [Related]
20. Antibacterial synergy between linezolid and baicalein against methicillin-resistant Staphylococcus aureus biofilm in vivo. Liu T; Luo J; Bi G; Du Z; Kong J; Chen Y Microb Pathog; 2020 Oct; 147():104411. PubMed ID: 32745664 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]